4-(Benzyloxy)-6-chloro-2-(methylthio)pyrimidin-5-amine

Catalog No.: 
ACETUP162
CAS No.: 
1196886-06-2
Molecular Formula: 
C12H12ClN3OS
Molecular Weight: 
281.77
4-(Benzyloxy)-6-chloro-2-(methylthio)pyrimidin-5-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$601.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Benzyloxy)-6-chloro-2-(methylthio)pyrimidin-5-amine
IUPAC Name4-(benzyloxy)-6-chloro-2-(methylthio)pyrimidin-5-amine
Molecular FormulaC12H12ClN3OS
Molecular Weight281.77
SMILESNC1=C(Cl)N=C(SC)N=C1OCC2=CC=CC=C2
InChI KeyOLMAJFVCDBVWFL-UHFFFAOYSA-N
Synonym4-(Benzyloxy)-6-chloro-2-(methylthio)pyrimidin-5-amine;5-Pyrimidinamine, 4-chloro-2-(methylthio)-6-(phenylmethoxy)-
CAS No.1196886-06-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACETUP162 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFZIR389 route compound structure diagram
    ACFZIR389333388-03-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACETUP162 route product structure diagram
    ACETUP1621196886-06-2
Inquiry

2. ACETUP162 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFZIR389 route compound structure diagram
    ACFZIR389333388-03-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACETUP162 route product structure diagram
    ACETUP1621196886-06-2
Inquiry

3. ACETUP162 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACETUP162 route product structure diagram
    ACETUP1621196886-06-2
Inquiry

Comments (0)